MSOX: Is a Move to $3.00 Realistic for This 2x Cannabis ETF?

Key Takeaways

• The $3.00 central target reflects public market discussion and a round-number technical milestone, not an official analyst consensus; leveraged ETFs like MSOX generally have no analyst price targets.
• At a latest verified price near $1.89, reaching $3.00 would require roughly 59% upside, a very large move even for this highly volatile fund.
• MSOX seeks about two times (2x) the daily return of the AdvisorShares Pure US Cannabis ETF (MSOS) through total-return swaps, resetting its leverage each trading day.
• There is no meaningful analyst target range; the fund's own 52-week range of roughly $1.62 to $11.88 illustrates how wide outcomes can be.
• The strongest support comes from potential US cannabis reform catalysts, including rescheduling, banking access, and 280E tax relief, plus the fund's ability to stage sharp short-term rallies.
• The biggest risks are daily reset decay, leverage, elevated embedded costs, a prolonged cannabis bear market, and the possibility of further reverse splits.
• For more detail on this ticker's Major News, Today's Price Move, Forecast, and Earnings, explore the dedicated pages linked here.
• To see AI-driven trade ideas across the market, explore Trending AI Robots.

Where the $3.00 Target Originates

MSOX is not a stock; it is an actively managed exchange-traded fund that uses swap agreements to target about two times the daily total return of MSOS, its unleveraged US cannabis sibling. Because ETFs do not receive conventional sell-side analyst price targets, no credible individual analyst targets or consensus figure exist to average. The $3.00 objective is therefore a fallback target drawn from public discussion and technical context rather than an analyst estimate.

The level is a round psychological milestone that MSOX traded near as recently as early September and early October 2026, and it sits close to where the fund's net asset value stood at the end of September, around $2.99. Framed this way, $3.00 represents a return toward recently traded levels, not a new all-time high. It should be read strictly as a publicly discussed objective, not a forecast or a guarantee. I also checked this using Tickeron’s AI Screener to see how the fund compares to others in the sector.

MSOX's Current Position and Path to the Target

As of late October 2026, MSOX traded near $1.89, close to the lower end of a 52-week range of about $1.62 to $11.88. Reaching $3.00 would require roughly 59% upside, which is a very large move. For a daily-reset leveraged fund, the path matters as much as the distance: because exposure resets each day, a choppy, side-to-side grind can erode value even when the underlying direction is roughly flat, whereas a sustained multi-day rally in MSOS could drive MSOX higher quickly.

MSOX's fortunes are tied almost entirely to US multi-state cannabis operators held through MSOS. A durable advance would likely require a sustained improvement in cannabis equities, not just a single-day bounce, because daily reset mechanics reward extended directional moves. From what I see, this leverage dynamic makes timing especially important.

Potential Catalysts That Could Support the Move

The clearest support is the possibility of US cannabis reform. Federal rescheduling of cannabis from Schedule I to Schedule III, passage of banking legislation such as the SAFE Banking Act, and relief from Section 280E tax treatment would directly improve the profitability and funding options of the multi-state operators that dominate MSOS and, in turn, MSOX. Any progress on these fronts has historically triggered sharp sector rallies.

The fund's 2x daily leverage also means a genuine sector recovery would be amplified on a daily basis, allowing MSOX to recover lost ground rapidly during strong stretches. Elevated volatility and heavy trading volume show the fund remains a preferred vehicle for traders seeking leveraged exposure to cannabis headlines.

Risks That Could Block the Target

The most significant obstacle is volatility decay. A 2x daily-reset fund can underperform two times its underlying over longer periods when markets are choppy, because losses compound and daily rebalancing works against the holder. MSOX has demonstrated this: its one-year return was deeply negative even relative to a weak cannabis sector.

Costs are also a headwind. The net expense ratio is roughly 0.97%, and the fund's total indirect cost of its swaps, including embedded costs and referenced-asset expenses, was reported near 7.63% in the most recent fiscal year, partly offset by interest on cash collateral. Added to this are sector-specific risks: stalled legislation, ongoing price compression in state markets, and the possibility of further reverse splits, one of which (a 1-for-20 split) occurred in late 2024.

Key Technical Levels to Watch

The $1.62 area represents the 52-week low and a key support zone, with the fund repeatedly finding buyers near $1.66 to $1.72 during 2026. The $3.00 objective sits near a prior trading zone and a level the fund tested around the end of September before sliding back. Above that, resistance extends toward the fund's former highs, with the 52-week high of $11.88 remaining far overhead. MSOX continues to trade below its longer-term moving averages, reflecting a persistent downtrend despite occasional sharp rallies.

Time Horizon and Monitoring Points

Because $3.00 is a publicly discussed milestone rather than a published analyst target, it carries no fixed research horizon. Traders should monitor US cannabis regulatory developments, including any rescheduling or banking-reform action, along with the earnings reports of the largest multi-state operators and changes in MSOS itself. Fund flows, NAV premium or discount, and sustained directional momentum in the underlying cannabis index are also important signals, since daily-reset leverage rewards persistence rather than one-off spikes. I'm watching this closely for any signs of regulatory momentum.

Final Assessment

The question of whether MSOX can reach $3.00 depends less on valuation than on the direction and persistence of the US cannabis sector, which drives MSOS and, through 2x daily leverage, MSOX. The roughly 59% move required is very large, yet it remains within levels the fund has traded in recent months. Reform catalysts such as rescheduling, banking access, and 280E relief provide a genuine upside case, while volatility decay, elevated costs, leverage, and an entrenched sector downtrend are meaningful counterweights. The $3.00 figure is a publicly discussed milestone, not a forecast, and investors should monitor regulatory news, cannabis operator earnings, fund flows, and technical momentum before drawing conclusions.

Incorporating AI Daily Buy/Sell Signals

In my own research process, I frequently review Tickeron's AI Daily Buy/Sell Signals to track how automated analysis aligns with the technical and regulatory factors affecting volatile funds like this one. The tool scans thousands of securities daily and flags Buy, Sell, or Hold signals based on market conditions and AI-driven patterns, which can help identify shifts in momentum more efficiently than manual checks alone. This approach has become a useful complement when evaluating leveraged products tied to fast-moving sectors.

Disclaimer

The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.

Disclaimers and Limitations

Contributor

Sergey Savastiouk|Expert

Sergey Savastiouk, Ph.D. has a degree in Applied Mathematics from Moscow University and has extensive experience as an entrepreneur, investor, manager, and mathematician. His professional expertise is in applied mathematics, mathematical modeling, system and pattern analysis, and software and hardware system integration. He has served as the CEO of several hi-tech start-up companies and nonprofit organizations, which has given him proven capabilities in business strategy for high-tech start-up companies, market assessment, company formation, team building, product development, marketing, and sales. He has published numerous articles in journals and magazines on related fields. As a retail investor, he spent 15 years developing his proprietary trading and quantitative algorithms (now Tickeron’s A.I.), which brought him significant returns in trading the stock market. His current work and goal in founding Tickeron is to bring professional, sophisticated stock market analysis capabilities to retail investors via an easy-to-use interface.

Industry description